Nikki Cannon has joined Reframe Cancer to head up its new patient cancer screening service.
Cannon (pictured) has extensive strategic and operational experience in the cancer field, including leading large scale transformation and change.
She has worked with the NHS, third sector, and healthcare providers.
In previous roles, Cannon led the transformation of personalised care and survivorship at Guy’s and St. Thomas’ NHS Trust, and developed a new cancer workforce engagement framework at Macmillan Cancer Support, where she was responsible for strategic oversight and policy advice for 10,000 professionals.
Cannon also joins Reframe Cancer’s Clinical Advisory Board, headed up by consultant clinical oncologist Dr Seema Dadhania.
Reframe’s new cancer screening service includes screening for bowel, cervical and prostate cancer via at home testing, as well as lung and breast cancer in clinic and skin cancer via mobile app through SkinVision.
Reframe’s screening platform delivers personalised NHS screening eligibility, cancer risk assessment and health guidance. Results will be followed up by one of Reframe Cancer’s cancer nurse specialists to discuss if any additional diagnostic testing is needed.
The product also operates with a flexible model that can be used to suit business needs, with self-pay, part funded by employer/policy, fully funded by employer/policy or included as part of a flexible benefits package all available.
Nikki Cannon, head of screening at Reframe Cancer, said: “I have always been passionate about improving the outcomes and experiences for people affected by cancer through earlier diagnosis and access to better treatments.
“Cancer screening is so important to tackling the rising UK cancer numbers, providing this service through Reframe will enable greater access to screening at a younger age for patients as well.
“The importance of this cannot be underestimated, being able to do this and offer it as a workplace benefit could save so many lives.”
Mark Stephenson, CEO at Reframe Cancer, added: “I am delighted that Nikki is leading Reframe’s cancer screening proposition.
“She understands the complexities of the NHS and private healthcare systems like no one else.
“Early detection and cancer screening is a vital component of tackling the rising UK cancer numbers, almost half of all cancer cases are diagnosed at stages 3 and 4 which is too late.
“Enabling greater access to cancer screening also supports the Long Term Plan set by the NHS which aims for the proportion of cancers diagnosed at stages 1 and 2 to rise from around half now to three-quarters of cancer patients by 2028.
“Offering cancer screening to insurers, employers and employees is a ground breaking part of Reframe’s growth and something we have spearheaded since becoming CQC registered.”
